Carbapenem-resistant Pseudomonas aeruginosa infections in critically ill children: Prevalence, risk factors, and impact on outcome in a large tertiary pediatric hospital of China

被引:14
|
作者
Huang, Weichun [1 ]
Wei, Xiaoshu [2 ]
Xu, Guifeng [3 ]
Zhang, Xingyu [1 ]
Wang, Xing [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Sch Med, Dept Lab Med, Shanghai, Peoples R China
[2] Fudan Univ, Huashan Hosp, Dept Nursing, Shanghai, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Innovat Res Inst Tradit Chinese Med, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
carbapenem-resistant Pseudomonas aeruginosa; pediatric; risk factor; mortality; antimicrobial resistance; INTENSIVE-CARE-UNIT; NOSOCOMIAL INFECTIONS; EPIDEMIOLOGY; SURVEILLANCE; SEPSIS;
D O I
10.3389/fpubh.2023.1088262
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background and aimsCarbapenem-resistant Pseudomonas aeruginosa (CRPA) is a major cause of healthcare-associated infections worldwide, but comprehensive study of clinical characteristics for CRPA infections among critically ill children remains limited in China. The objective of this study was to determine the epidemiology, risk factors, and clinical outcomes of CRPA infections among critically ill pediatric patients in a large tertiary pediatric hospital in China. MethodsA retrospective case-control study of patients with P. aeruginosa infections was conducted in the three intensive care units (ICUs) of Shanghai Children's Medical Center from January 2016 to December 2021. All patients with CRPA infection in the ICUs were enrolled as case patients. Patients with carbapenem-susceptible P. aeruginosa (CSPA) infection were randomly selected as control patients in a ratio of 1:1. Clinical characteristics of those inpatients were reviewed through the hospital information system. Univariate and multivariate analyses were performed to evaluate risk factors associated with the development of CRPA infections and mortality of P. aeruginosa infections. ResultsA total of 528 cases of P. aeruginosa infection in the ICUs were enrolled in the 6-year study. The prevalence of CRPA and MDRPA (multidrug-resistance P. aeruginosa) was 18.4 and 25.6%, respectively. Significant risk factors related to CRPA infection were the length of hospitalization >28 days (OR = 3.241, 95% CI 1.622-6.473, p = 0.001), receiving invasive operations (OR = 2.393, 95% CI 1.196-4.788, p = 0.014) and a blood transfusion (OR = 7.003, 95% CI 2.416-20.297, p < 0.001) within 30 days before infection. Conversely, birth weight >= 2,500 g (OR = 0.278, 95% CI 0.122-0.635, p = 0.001) and breast nursing (OR = 0.362, 95% CI 0.168-0.777, p = 0.009) were significant protective factors against CRPA infections. The in-hospital mortality rate was 14.2%, and no difference in mortality was observed between patients with CRPA and CSPA infections. Platelet < 100 x 10(9)/L (OR = 5.729, 95% CI 1.048-31.308, p = 0.044) and serum urea <3.2 mmol/L (OR = 5.173, 95% CI 1.215-22.023, p = 0.026) were independent predictors for the mortality due to P. aeruginosa infection. ConclusionsOur findings provide insights into CRPA infections among critically ill children in China. They provide guidance in identifying patients that may be at high risk for a resistant infection and emphasize the importance of antimicrobial stewardship and infection control in hospitals.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome
    de Maio Carrilho, Claudia M. D.
    de Oliveira, Larissa Marques
    Gaudereto, Juliana
    Perozin, Jamile S.
    Urbano, Mariana Ragassi
    Camargo, Carlos H.
    Grion, Cintia M. C.
    Levin, Anna Sara S.
    Costa, Silvia F.
    BMC INFECTIOUS DISEASES, 2016, 16
  • [22] Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella pneumoniae Infections in Eastern China
    Zheng, Bing
    Dai, Yingxin
    Liu, Yang
    Shi, Weiyang
    Dai, Erkuan
    Han, Yichao
    Zheng, Dandan
    Yu, Yuetian
    Li, Min
    FRONTIERS IN MICROBIOLOGY, 2017, 8
  • [23] Bloodstream infections in children caused by carbapenem-resistant versus carbapenem-susceptible gram-negative microorganisms: Risk factors and outcome
    Ozsurekci, Yasemin
    Aykac, Kubra
    Cengiz, Ali Bulent
    Basaranoglu, Sevgen Tanir
    Sancak, Banu
    Karahan, Sevilay
    Kara, Ates
    Ceyhan, Mehmet
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2017, 87 (04) : 359 - 364
  • [24] Carbapenem Resistant Pseudomonas aeruginosa Infections in Elderly Patients: Antimicrobial Resistance Profiles, Risk Factors and Impact on Clinical Outcomes
    Qin, Jie
    Zou, Chengyun
    Tao, Jianmin
    Wei, Tian
    Yan, Li
    Zhang, Yufei
    Wang, Haiying
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 2301 - 2314
  • [25] Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China
    Li, Yuanyuan
    Li, Jihong
    Hu, Tong
    Hu, Jia
    Song, Ning
    Zhang, Yu
    Chen, Yuan
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2020, 9 (01)
  • [26] Characteristics of Klebsiella bloodstream infections and risk factors for carbapenem-resistant Klebsiella infections in children
    Yahsi, Aysun
    Bayhan, Gulsum Iclal
    Arslan, Emel
    Gokdol, Muhammed Yasin
    Atay, Beyza Nur
    Karaciger, Seren
    Yuksek, Saliha Kanik
    Gulhan, Belgin
    Parlakay, Aslinur Ozkaya
    TRENDS IN PEDIATRICS, 2023, 4 (02): : 133 - 142
  • [27] Pseudomonas aeruginosa bloodstream infections in children and adolescents: risk factors associated with carbapenem resistance and mortality
    Rodriguez, N. E. G.
    Aguilera-Alonso, D.
    Escosa, L.
    Gomez-Gil, M. R.
    Manzanares, A.
    Ascaso, M. G.
    Bermejo-Gomez, A.
    Abad, M. J. G.
    Ramos, A. M.
    Nunez, A. S.
    Orellana, M. A.
    Cercenado, E.
    Lozano, J. S.
    Calvo, C.
    Baquero-Artigao, F.
    JOURNAL OF HOSPITAL INFECTION, 2024, 149 : 56 - 64
  • [28] Impact of Combination Antimicrobial Therapy on Mortality Risk for Critically Ill Patients with Carbapenem-Resistant Bacteremia
    Bass, Stephanie N.
    Bauer, Seth R.
    Neuner, Elizabeth A.
    Lam, Simon W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (07) : 3748 - 3753
  • [29] Virulence factors, molecular characteristics, and resistance mechanisms of carbapenem-resistant Pseudomonas aeruginosa isolated from pediatric patients in Shanghai, China
    Yin, Lijun
    Bao, Zihao
    He, Leiyan
    Lu, Lu
    Lu, Guoping
    Zhai, Xiaowen
    Wang, Chuanqing
    BMC MICROBIOLOGY, 2025, 25 (01):
  • [30] The impact of carbapenem-resistant Pseudomonas aeruginosa on clinical and economic outcomes in a Chinese tertiary care hospital: A propensity score-matched analysis
    Chen, Zhihui
    Xu, Ziqin
    Wu, Hongmei
    Chen, Le
    Gao, Shengchun
    Chen, Yangfang
    AMERICAN JOURNAL OF INFECTION CONTROL, 2019, 47 (06) : 677 - 682